•Innovative immunotherapies, such as CAR T cell therapies targeting GD2 and EGFR, NK cell-based treatments, and TCR-transduced T cells, are under active investigation, representing cutting-edge approaches to enhance immune-mediated tumor control in EwS. The gene discussed is EGFR; the disease is neoplasm.